Status:
UNKNOWN
68Ga-P16-093 PET/CT Imaging in the Salivary Gland
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Primary Sjögren Syndrome
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
PHASE2
Brief Summary
Prostate specific membrane antigen (PSMA) is a type II transmembrane protein and acts as a glutamate carboxypeptidase enzyme. It is first described in prostate cancer cell lines and later identified i...
Detailed Description
Primary sjogren's syndrome (pSS) is a systemic autoimmune disease mainly presented hyperglobulinemia and exocrine gland involvement,and lack of diagnostic gold standard.Prostate-specific membrane anti...
Eligibility Criteria
Inclusion
- pathological diagnosis confirmed by operation or biopsy.
- Obtain written informed consent and accepted follow-up.
Exclusion
- Pregnant, lactating women or having parenting plans during the study
- Head and neck radiotherapy history ;
- Active hepatitis C infection (PCR positive), include immunodeficiency syndrome, sarcoidosis, amyloidosis, graft versus host disease, IgG4 related diseases.
- Other situaition researchers considered it was not appropriate to participate in trials.
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06049368
Start Date
October 1 2023
End Date
March 31 2024
Last Update
September 22 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.